SUCCESSFUL USE OF THE HEPARINOID DANAPAROID-SODIUM DURING AORTIC-VALVE PROTHESIS REPLACEMENT IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II
E. Scheffler et al., SUCCESSFUL USE OF THE HEPARINOID DANAPAROID-SODIUM DURING AORTIC-VALVE PROTHESIS REPLACEMENT IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II, Zeitschrift fur Kardiologie, 84(7), 1995, pp. 565-568
The 29-year-old, heroin-addicted patient received an aortic valve prot
hesis (SJM) 10 years ago because of aortic valve stenosis III. One yea
r after surgical treatment he refused to take Phenprocoumon and thus r
eceived no anticoagulation for 9 years. The patient was hospitalized d
ue to cardial decompensation and thrombosis of the aortic valve prothe
sis was diagnosed. Under heparinization, he developed heparin-induced
thrombocytopenia type II, which disappeared after changing the medicat
ion to Danaparoid-Sodium. In order to avoid any further heparin exposu
re, we also carried out the surgical replacement of the aortic valve p
rothesis under anticoagulation with Danaparoid-Sodium.